Earnings Release • Mar 26, 2024
Earnings Release
Open in ViewerOpens in native device viewer
Washington, D.C. 20549
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934
March 26, 2024
Commission File Number 001-36761
1 Temasek Avenue #37-02B Millenia Tower Singapore 039192 (Address of principal executive offices)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F ☒ Form 40-F ☐
EXHIBITS 99.1 AND 99.2 TO THIS REPORT ON FORM 6-K ARE INCORPORATED BY REFERENCE IN THE REGISTRATION STATEMENT ON FORM S-8 (FILE NO. 333-201716) OF KENON HOLDINGS LTD. AND IN THE PROSPECTUSES RELATING TO SUCH REGISTRATION STATEMENT.
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
Date: March 26, 2024 By: /s/ Robert L. Rosen Name: Robert L. Rosen Title: Chief Executive Officer
Exhibit 99.1

Singapore, March 26, 2024. Kenon Holdings Ltd. (NYSE: KEN, TASE: KEN) ("Kenon") announces its results for 2023 and additional updates.
Kenon
• In March 2024, Kenon's board of directors approved a cash dividend of approximately \$200 million (\$3.80 per share) payable in April 2024.
OPC
1 Adjusted EBITDA is a non-IFRS measure. See Exhibit 99.2 of Kenon's Form 6-K dated March 26, 2024 for the definition of OPC's EBITDA and Adjusted EBITDA (including proportionate share in Adjusted EBITDA of associated companies) and ZIM's Adjusted EBITDA and a reconciliation to their respective net (loss)/profit for the applicable period. 2 Represents 100% of ZIM's results. Kenon owns and owned during the years ended December 31, 2023 and December 31, 2022 approximately 21% of ZIM.
Kenon's consolidated results of operations from its operating companies essentially comprise the consolidated results of OPC Energy Ltd ("OPC"). Our share of the results of ZIM Integrated Shipping Ltd. ("ZIM") is reflected under results from associated companies.
See Exhibit 99.2 of Kenon's Form 6-K dated March 26, 2024 for a summary of Kenon's consolidated financial information; a summary of OPC's consolidated financial information; a reconciliation of OPC's EBITDA and Adjusted EBITDA (including proportionate share in Adjusted EBITDA of associated companies) (which is a non-IFRS measure) to profit for the period; a summary of financial information of OPC's subsidiaries; and a reconciliation of ZIM's Adjusted EBITDA (which is a non-IFRS measure) to (loss)/profit for the period.
OPC
The following discussion of OPC's results of operations is derived from OPC's consolidated financial statements, which are denominated in NIS for purposes of OPC's financial statements, as translated into US dollars for Kenon's financial statements.
| For the year ended December 31, |
|||
|---|---|---|---|
| 2023 | 2022 | ||
| \$ millions | |||
| Revenue | 692 | 574 | |
| Cost of sales (excluding depreciation and amortization) | (494) | (417) | |
| Finance expenses, net | (53) | (14) | |
| Share in profit of associated companies, net | 66 | 85 | |
| Profit for the period | 47 | 65 | |
| Attributable to: | |||
| Equity holders of OPC | 40 | 50 | |
| Non-controlling interest | 7 | 15 | |
| Adjusted EBITDA3 | 304 | 250 |
For details of OPC's results please refer to Appendix B.
Revenue
| For the year ended December 31, |
||
|---|---|---|
| 2023 | 2022 | |
| \$ millions | ||
| Israel | 619 | 517 |
| U.S. | 73 | 57 |
| Total | 692 | 574 |
OPC's revenue increased by \$118 million in 2023 as compared to 2022. Excluding the impact of translating OPC's revenue from NIS to USD4 , OPC's revenue increased by \$169 million in 2023 as compared to 2022. Set forth below is a discussion of significant changes in revenue between 2023 and 2022.
OPC's revenue from the sale of electricity to private customers is derived from electricity sold at the generation component tariffs, as published by the Israeli Electricity Authority ("EA"), with some discount. Accordingly, changes in the generation component tariffs generally affect the prices paid by customers under Power Purchase Agreements of OPC-Rotem and OPC-Hadera. The weighted-average generation component tariff in 2023 was NIS 30.53 per KW hour, which is approximately 4% higher than the weighted-average generation component tariff in 2022 of NIS 29.27 per KW hour.
3 Non-IFRS measure. See Appendix C for a definition of OPC's Adjusted EBITDA and a reconciliation to profit for the period.
4 The table above and corresponding comparison relating to 2023 and 2022 were converted using an average exchange rate of \$0.2710/NIS.
Set forth below is a discussion of changes in the key components in revenue for 2023 as compared to 2022.
| For the year ended December 31, | ||
|---|---|---|
| 2023 | 2022 | |
| \$ millions | ||
| Israel | 453 | 385 |
| U.S. | 41 | 32 |
| Total | 494 | 417 |
OPC's cost of sales (excluding depreciation and amortization) increased by \$77 million from 2022 to 2023. Excluding the impact of translating OPC's cost of sales (excluding depreciation and amortization) from NIS to USD5 , OPC's cost of sales (excluding depreciation and amortization) increased by \$115 million in 2023 as compared to 2022. Set forth below is a discussion of significant changes in cost of sales between 2023 and 2022.
5 Comparing 2023 and 2022 using the average exchange rate of \$0.2710/NIS.
Finance expenses, net in 2023 was \$53 million, as compared to \$14 million in 2022, primarily due to (i) an increase in interest expense relating to loans for the Gat Power Plant and the Mountain Wind project of \$7 million and \$4 million, respectively, and (ii) an increase in interest expense from the commencement of commercial operations of Tzomet Power Plant of \$8 million, partially offset by (iii) an increase in interest income from deposits.
OPC's share of profit of associated companies, net decreased by \$19 million in 2023 as compared in 2022, primarily as a result of a decrease in energy margins compared with 2022, partially offset by increased availability of CPV Valley Power Plant in 2023 as compared to 2022 when the power plant was undergoing maintenance work.
For further details of the performance of associated companies of CPV, refer to OPC's immediate report published on the Tel Aviv Stock Exchange ("TASE") on March 12, 2024 and the convenience English translations of OPC's Board of Directors Report and Financial Statements for the year ended December 31, 2023 furnished by Kenon on Form 6-K on March 12, 2024.
As of December 31, 2023, OPC had cash and cash equivalents of \$278 million (excluding restricted cash and including debt service reserves of \$91 million), restricted cash of \$17 million, and total outstanding consolidated indebtedness of \$1,530 million, consisting of \$170 million of short-term indebtedness and \$1,360 million of long-term indebtedness. As of December 31, 2023, a substantial portion of OPC's debt was denominated in NIS.
As of December 31, 2023, OPC's proportionate share of debt (including accrued interest) of CPV associated companies was \$839 million and proportionate share of cash and cash equivalents was \$25 million.
On February 1, 2024, the annual update of the electricity tariffs of the EA for 2024 entered into effect, decreasing the generation component by 1.1% to NIS 0.3007 per KW hour.
In March 2024, OPC reported that the EA issued a resolution (the "Supply License Resolution") regarding the hearing on complementary arrangements and the application of certain regulatory standards to OPC-Rotem (in which OPC has an 80% indirect stake). The Supply License Resolution will come into force on May 1, 2024. See our Annual Report on Form 20-F for the year ended December 31, 2023 for more information.
ZIM carried approximately 3,281 thousand TEUs in 2023 representing approximately a 3% decrease as compared to 2022, in which ZIM carried approximately 3,380 thousand TEUs. The average freight rate in 2023 was \$1,203 per TEU, representing approximately a 63% decrease as compared to \$3,240 per TEU in 2022.
ZIM's revenues decreased by approximately 59% in 2023 to \$5.2 billion, as compared to \$12.6 billion in 2022, primarily due to a decrease in freight rates.
ZIM's operating loss and net loss was \$2.5 billion and \$2.7 billion, respectively, in 2023, as compared to operating income and net income of \$6.1 billion and \$4.6 billion, respectively, in 2022. Operating loss in 2023 includes a non-cash impairment of \$2.1 billion. ZIM's Adjusted EBITDA1 in 2023 was \$1 billion as compared to \$7.5 billion in 2022.
ZIM's total cash (which includes cash and cash equivalents and investments in bank deposits and other investment instruments) was \$2.7 billion as of December 31, 2023, as compared to \$4.6 billion as of December 31, 2022.
6 Represents 100% of ZIM's results. Kenon owns and owned during the years ended December 31, 2023 and December 31, 2022 approximately 21% of ZIM.

As of December 31, 2023, Kenon's stand-alone cash was \$634 million. As of March 26, 2024, Kenon's stand-alone cash was \$639 million. There is no material debt at the Kenon level.
Kenon's stand-alone cash includes cash and cash equivalents and other treasury management instruments.
In March 2024, Kenon's board of directors approved an interim cash dividend of approximately \$200 million (\$3.80 per share) (the "Dividend") relating to the year ending December 31, 2024, payable to Kenon's shareholders of record as of the close of trading on April 8, 2024 (the "Record Date"), to be paid on or about April 15, 2024 (the "Payment Date").
The New York Stock Exchange's (the "NYSE") ex-dividend date, which is the date on which Kenon's shares will begin trading on the NYSE without the entitlement to the Dividend, is April 5, 2024.
The TASE ex-dividend date, which is the date on which Kenon's shares will begin trading on the TASE without the entitlement to the Dividend, is April 8, 2024.
We encourage you to contact your bank, broker, nominee or other institution if you have any questions regarding the mechanics and timing of having the Dividend attributable to your shares credited to your account.
Singapore tax is not expected to be imposed on Kenon's shareholders in connection with the Dividend. Nevertheless, the Dividend may constitute a taxable event to Kenon's shareholders according to their jurisdiction and the relevant tax law applicable (including for the purpose of withholding tax in accordance with applicable law and/or regulation). Kenon's shareholders should consult their tax advisors with respect to the federal, state, and/or any other applicable tax consequences of the Dividend, and the potential imposition of withholding taxes in connection with the Dividend.
In October 2023, an arbitration tribunal constituted by the International Centre for Settlement of Investment Disputes ("ICSID") delivered a final award (the "ICSID Award") in favor of Kenon and IC Power Ltd. ("IC Power") in an arbitration proceeding against the Republic of Peru ("Peru") under the Free Trade Agreement between Singapore and Peru. Pursuant to the ICSID Award, Peru has been ordered to pay Kenon and IC Power a total of \$110.7 million in damages, together with \$5.5 million in fees and costs and pre-award and post-award interest. Pursuant to Article 49 of the ICSID Convention, the parties have submitted requests seeking rectification of and/or supplementation to the ICSID Award relating to the tribunal's award of interest and costs. These requests do not impact the tribunal's principal award of damages. Kenon is taking steps to enforce the ICSID Award.
As previously disclosed in Kenon's Form 20-F, Kenon and IC Power have previously entered in an agreement with a capital provider to provide capital for expenses in relation to the pursuit of these arbitration claims and other costs. In the event that Kenon or IC Power receives proceeds in connection with the ICSID Award or settlement thereof, the capital provider will be entitled to be repaid the amount committed by the capital provider and to receive a portion of the claim proceeds.
The ICSID Award is subject to tax.
In February 2024, the China International Economic and Trade Arbitration Commission ("CIETAC") issued a final award (the "CIETAC Award") in favor of Kenon's wholly-owned subsidiary Quantum (2007) LLC ("Quantum") with respect to arbitral proceedings initiated by Quantum in 2021 against an entity related to Shenzhen Baoneng Investment Group Co., Ltd. ("Baoneng Group"), which holds 63% of Qoros (the "Qoros Majority Shareholder") and Baoneng Group in connection with the agreement for the sale of Quantum's remaining 12% interest in Qoros to the Majority Qoros Shareholder. The tribunal ruled that the Qoros Majority Shareholder and Baoneng Group are obligated to pay Quantum approximately RMB 1.9 billion (approximately \$268 million) comprising the purchase price set forth in the Sale Agreement (as adjusted for inflation) of approximately RMB 1.7 billion (approximately \$239 million), together with pre-award and postaward interest, legal fees and expenses. Any value that could be realized in respect of the CIETAC Award is subject to significant risks and uncertainties, including risks relating to enforcement and collection of the CIETAC Award and other risks and uncertainties.
In addition, the lenders under Qoros' RMB 1.2 billion loan facility have obtained a court order in respect of a payment default by Qoros, subject to Baoneng Group's appeal against such order. The court order (when effective) would, among other things, enable the lenders to take steps to enforce pledges over Qoros' assets and other security for the loan including the shares in Qoros pledged by its shareholders to secure the loan, including Quantum's pledge of its 12% interest in Qoros.
Kenon has interests in the following businesses:
Kenon has agreed to sell its remaining 12% interest of Qoros, a China-based automotive company to the Majority Shareholder.
For further information on Kenon, including its businesses and strategy, see Kenon's publicly available filings, which can be found on the SEC's website at www.sec.gov. Please also see www.kenon-holdings.com for additional information.
This press release includes forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements include statements relating to (i) with respect to OPC, including tariff rates, and the Supply License Resolution, including the provisions thereof, (ii) Kenon's announced dividend, (iii) the ICSID Award including interest payable on the ICSID Award, procedural steps that have been or may be taken with respect to the ICSID Award and the agreement with a capital provider and its entitlement to a portion of the ICSID Award, (iv) the CIETAC Award and Quantum's intention to enforce the CIETAC Award, the court order in respect of the payment default by Qoros and impact of such order and (v) other non-historical matters. These statements are based on current expectations or beliefs and are subject to uncertainty order and changes in circumstances. These forward-looking statements are subject to a number of risks and uncertainties, many of which are beyond Kenon's control, which could cause the actual results to differ materially from those indicated in such forward-looking statements. Such risks include (i) tariff rates applicable to OPC for 2024, and risks relating to the terms of the Supply License Resolution and the impact on OPC-Rotem, and other risks, (ii) risks relating to payment of Kenon's announced dividend, (iii) risks relating to the ICSID Award including a potential application to annul the ICSID Award, Kenon's ability to enforce the ICSID Award and collect the amounts awarded thereunder and interest payable thereon, and amounts payable to the capital provider and to Kenon, (iv) risks related to the CIETAC Award, including the risk that Quantum may be unable to enforce the CIETAC Award or otherwise collect the amounts awarded or otherwise owing to it, and risks relating to the order in respect of the payment default by Qoros and the pledge by Quantum of its 12% interest in Qoros including the risk of enforcement of the pledge and impact thereof and (v) other risks and factors including those risks set forth under the heading "Risk Factors" in Kenon's most recent Annual Report on Form 20-F filed with the SEC and other filings. Except as required by law, Kenon undertakes no obligation to update these forward-looking statements, whether as a result of new information, future events, or otherwise.
Kenon Holdings Ltd. Deepa Joseph Chief Financial Officer [email protected] Tel: +65 9669 4761

Exhibit 99.2
Appendix A: Summary of Kenon's consolidated financial information
Appendix B: Summary of OPC's consolidated financial information
Appendix C: Definition of OPC's Adjusted EBITDA and non-IFRS reconciliation
Appendix D: Summary of financial information of OPC's subsidiaries
Appendix E: Definition of ZIM's Adjusted EBITDA and non-IFRS reconciliation
Summary Kenon consolidated financial information
Consolidated Statements of Financial Position as of December 31, 2023 and 2022
| 2023 2022 \$ millions Current assets Cash and cash equivalents 697 Short-term deposits and restricted cash 1 Trade receivables 68 Short-term derivative instruments 3 Other investments 216 Other current assets 111 Total current assets 1,096 Non-current assets Investment in ZIM (associated company) - Investment in OPC's associated companies 703 Long-term restricted cash 16 Long-term derivative instruments 14 Deferred taxes, net 16 Property, plant and equipment, net 1,715 Intangible assets, net 321 Long-term prepaid expenses and other non-current assets 52 Right-of-use assets, net 175 Total non-current assets 3,012 Total assets 4,108 Current liabilities Current maturities of loans from banks and others 170 Trade and other payables 182 Short-term derivative instruments 2 Current tax liabilities - Deferred taxes - Current maturities of lease liabilities 5 Total current liabilities 359 Non-current liabilities Long-term loans from banks and others 906 Debentures 454 Deferred taxes, net 137 |
|---|
| 535 46 74 3 345 59 1,062 427 652 15 16 6 1,223 221 23 127 2,710 3,772 39 134 1 1 1 17 193 610 513 98 |
| Other non-current liabilities 110 42 |
| Long-term derivative instruments 16 - |
| Long-term lease liabilities 56 20 |
| Total non-current liabilities 1,679 1,283 |
| Total liabilities 2,038 1,476 |
| Equity |
| Share capital 50 50 |
| Translation reserve (4) 1 |
| Capital reserve 70 42 |
| Accumulated profit 1,087 1,505 |
| Equity attributable to owners of the Company 1,203 1,598 |
| Non-controlling interests 867 698 |
| Total equity 2,070 2,296 |
| Total liabilities and equity 4,108 3,772 |
* Reclassified
| For the year ended December 31, | |||
|---|---|---|---|
| 2023 | 2022 | ||
| \$ millions | |||
| Revenue | 692 | 574 | |
| Cost of sales and services (excluding depreciation and amortization) | (494) | (417) | |
| Depreciation and amortization | (78) | (57) | |
| Gross profit | 120 | 100 | |
| Selling, general and administrative expenses | (86) | (100) | |
| Other income | 8 | 3 | |
| Operating profit | 42 | 3 | |
| Financing expenses | (66) | (50) | |
| Financing income | 39 | 45 | |
| Financing expenses, net | (27) | (5) | |
| Losses related to ZIM | (1) | (728) | |
| Share in (losses)/profit of associated companies, net | |||
| - ZIM |
(266) | 1,033 | |
| OPC's associated companies - |
66 | 85 | |
| (Loss)/profit before income taxes | (186) | 388 | |
| Income tax expense | (25) | (38) | |
| (Loss)/profit for the period | (211) | 350 | |
| Attributable to: | |||
| Kenon's shareholders | (236) | 313 | |
| Non-controlling interests | 25 | 37 | |
| (Loss)/profit for the period | (211) | 350 | |
| Basic/diluted (loss)/profit per share attributable to Kenon's shareholders (in dollars): | |||
| Basic/diluted (loss)/profit per share | (4.42) | 5.80 |
| For the year ended December 31, | |||
|---|---|---|---|
| 2023 | 2022 | ||
| \$ millions | |||
| Cash flows from operating activities | |||
| (Loss)/profit for the period | (211) | 350 | |
| Adjustments: | |||
| Depreciation and amortization | 91 | 63 | |
| Financing expenses, net | 27 | 5 | |
| Losses related to ZIM | 1 | 728 | |
| Share in losses/(profit) of associated companies, net | 200 | (1,118) | |
| Share-based payments | (2) | 20 | |
| Other expenses, net | 5 | - | |
| Income tax expense | 25 | 38 | |
| 136 | 86 | ||
| Change in trade and other receivables | (3) | (29) | |
| Change in trade and other payables | (9) | (11) | |
| Cash generated from operating activities | 124 | 46 | |
| Income taxes paid, net | (2) | (2) | |
| Dividends received from associated companies | |||
| ZIM - |
151 | 727 | |
| OPC's associated company - |
4 | ||
| Net cash provided by operating activities | 277 | 771 | |
| For the year ended December 31, | ||
|---|---|---|
| 2023 | 2022 | |
| \$ millions | ||
| Cash flows from investing activities | ||
| Short-term deposits and restricted cash, net | 50 | (46) |
| Short-term collaterals deposits, net | 30 | (19) |
| Investment in long-term deposits, net | - | 13 |
| Investment in associated companies, less cash acquired | (8) | (3) |
| Acquisition of subsidiary, less cash acquired | (327) | - |
| Acquisition of property, plant and equipment, intangible assets and payment of | ||
| long-term advance deposits and prepaid expenses | (332) | (281) |
| Proceeds from sale of interest in ZIM | - | 464 |
| Proceeds from distribution from associated company | 3 | 4 |
| Proceeds from sale of subsidiary, net of cash disposed off | 2 | - |
| Proceeds from sale of other investments | 194 | 309 |
| Purchase of other investments | (50) | (651) |
| Long-term loans to an associate | (24) | - |
| Interest received | 28 | 6 |
| Proceeds from transactions in derivatives, net | 2 | 1 |
| Net cash used in investing activities | (432) | (203) |
| Cash flows from financing activities | ||
| Repayment of long-term loans, debentures and lease liabilities | (168) | (56) |
| Proceed from short-term loans from banking corporations | 62 | 102 |
| Proceed from Veridis transaction | 129 | - |
| Proceeds from issuance of share capital by a subsidiary to non-controlling | ||
| interests, net of issuance expenses | - | 193 |
| Investments from holders of non-controlling interests in the capital of a subsidiary | 64 | 37 |
| Tax equity investment | 82 | - |
| Receipt from long-term loans | 392 | - |
| Proceeds from/(payment) in respect of derivative financial instruments, net | 2 | (1) |
| Repurchase of shares | (28) | - |
| Costs paid in advance in respect of taking out of loans | (20) | (3) |
| Cash distribution and dividends paid | (150) | (741) |
| Interest paid | (41) | (25) |
| Net cash provided by/(used in) financing activities | 324 | (494) |
| Increase in cash and cash equivalents | 169 | 74 |
| Cash and cash equivalents at beginning of the year | 535 | 475 |
| Effect of exchange rate fluctuations on balances of cash and cash equivalents | (7) | (14) |
| Cash and cash equivalents at end of the period | 697 | 535 |
Information regarding activities of the reportable segments are set forth in the following table.
| For the year ended December 31, 2023 | |||||
|---|---|---|---|---|---|
| OPC Israel | CPV Group | ZIM \$ millions |
Other | Consolidated Results |
|
| Revenue | 619 | 73 | - | - | 692 |
| Depreciation and amortization | 66 | 25 | - | - | 91 |
| Financing income | 6 | 6 | - | 27 | 39 |
| Financing expenses | (48) | (17) | - | (1) | (66) |
| Losses related to ZIM | - | - | (1) | - | (1) |
| Share in profit/(loss) of associated companies | - | 66 | (266) | - | (200) |
| Profit/(loss) before taxes | 49 | 17 | (267) | 15 | (186) |
| Income tax expense | (14) | (5) | - | (6) | (25) |
| Profit/(loss) for the period | 35 | 12 | (267) | 9 | (211) |
| Adjusted EBITDA | 157 | 147 | - | (10) | 294 |
| For the year ended December 31, 2022 | |||||
|---|---|---|---|---|---|
| OPC Israel | CPV Group | ZIM | Other | Consolidated Results |
|
| \$ millions | |||||
| Revenue | 517 | 57 | - | - | 574 |
| Depreciation and amortization | (47) | (16) | - | - | (63) |
| Financing income | 10 | 25 | - | 10 | 45 |
| Financing expenses | (42) | (7) | - | (1) | (50) |
| Gains related to ZIM | - | - | (728) | - | (728) |
| Share in profit of associated companies | - | 85 | 1,033 | - | 1,118 |
| Profit/(loss) before taxes | 24 | 61 | 305 | (2) | 388 |
| Income tax expense | (10) | (10) | - | (18) | (38) |
| Profit/(loss) for the period | 14 | 51 | 305 | (20) | 350 |
| Adjusted EBITDA | 103 | 147 | - | (11) | 239 |
| 6 |
Summary of OPC consolidated financial information
OPC's Consolidated Statements of Profit or Loss
| For the year ended December 31, | |||
|---|---|---|---|
| 2023 | 2022 | ||
| \$ millions | |||
| Revenue | 692 | 574 | |
| Cost of sales (excluding depreciation and amortization) | (494 ) |
(417 ) |
|
| Depreciation and amortization | (78 ) |
(57 ) |
|
| Gross profit | 120 | 100 | |
| Selling, general and administrative expenses | (73 ) |
(86 ) |
|
| Other income, net | 6 | - | |
| Operating profit | 53 | 14 | |
| Financing expenses | (65 ) |
(49 ) |
|
| Financing income | 12 | 35 | |
| Financing expenses, net | (53 ) |
(14 ) |
|
| Share in profit of associated companies, net | 66 | 85 | |
| Profit before income taxes | 66 | 85 | |
| Income tax expense | (19 ) |
(20 ) |
|
| Profit for the period | 47 | 65 | |
| Attributable to: | |||
| Equity holders of the company | 40 | 50 | |
| Non -controlling interest |
7 | 15 | |
| Profit for the period | 47 | 65 |
| For the year ended December 31, | ||
|---|---|---|
| 2023 | 2022 | |
| \$ millions | ||
| Cash flows provided by operating activities | 135 | 63 |
| Cash flows used in investing activities | (594) | (329) |
| Cash flows provided by financing activities | 503 | 286 |
| Increase in cash and cash equivalents | 44 | 20 |
| Cash and cash equivalents at end of the period | 278 | 241 |
Summary Data from OPC's Consolidated Statement of Financial Position
| As at | ||
|---|---|---|
| December 31, 2023 |
December 31, 2022 |
|
| \$ millions | ||
| Total financial liabilities1 | 1,530 | 1,163 |
| Total monetary assets2 | 278 | 287 |
| Investment in associated companies | 703 | 652 |
| Total equity attributable to the owners | 1,061 | 997 |
| Total assets | 3,479 | 2,709 |
Including loans from banks and others and debentures
Including cash and cash equivalents, term deposits and restricted cash
This press release, including the financial tables, presents OPC's Adjusted EBITDA, which is a non-IFRS financial measure.
OPC's EBITDA is defined for each period as net profit/(loss) before depreciation and amortization, financing expenses, net, share of depreciation and amortization and financing expenses, net, included within share of profit of associated companies, net and income tax expense. OPC's Adjusted EBITDA is defined as net profit/(loss) before depreciation and amortization, financing expenses, net, share of depreciation and amortization and financing expenses, net, included within share of profit of associated companies, net, income tax expense, changes in net expenses, not in the ordinary course of business and/or of a non-recurring nature, other income/(expenses) and share of changes in fair value of derivative financial instruments. EBITDA and Adjusted EBITDA are not recognized under IFRS as a measure of financial performance and should not be considered as a substitute for net profit or loss, cash flow from operations or other measures of operating performance determined in accordance with IFRS. EBITDA and Adjusted EBITDA are not intended to represent funds available for dividends or other discretionary uses because those funds may be required for debt service, capital expenditures, working capital and other commitments and contingencies. There are limitations that impair the use of EBITDA and Adjusted EBITDA as measures of OPC's profitability since it does not take into consideration certain costs and expenses that result from OPC's business that could have a significant effect on net profit, such as financial expenses, taxes, and depreciation and amortization.
OPC believes that the disclosure of EBITDA and Adjusted EBITDA provides useful information to investors and financial analysts in their review of the company's, its subsidiaries', and its associated companies' operating performance and in the comparison of such operating performance to the operating performance of other companies in the same industry or in other industries that have different capital structures, debt levels and/or income tax rates.
Set forth below is a reconciliation of OPC's net profit to EBITDA and Adjusted EBITDA for the periods presented. Other companies may calculate EBITDA and Adjusted EBITDA differently, and therefore this presentation of EBITDA and Adjusted EBITDA may not be comparable to other similarly titled measures used by other companies.
| For the year ended December 31, | |||
|---|---|---|---|
| 2023 | 2022 | ||
| \$ millions | |||
| Profit for the period | 47 | 65 | |
| Depreciation and amortization | 91 | 63 | |
| Financing expenses, net | 53 | 14 | |
| Share of depreciation and amortization and financing expenses, net, included within share of profit of associated | |||
| companies, net | 91 | 83 | |
| Income tax expense | 19 | 20 | |
| EBITDA | 301 | 245 | |
| Changes in net expenses, not in the ordinary course of business and/or of a non-recurring nature | 5 | 2 | |
| Share of changes in fair value of derivative financial instruments | (2) | 3 | |
| Adjusted EBITDA | 304 | 250 |
The tables below set forth debt, cash and cash equivalents, and debt service reserves for OPC's subsidiaries as of December 31, 2023 and December 31, 2022 (in \$ millions):
| As of December 31, 2023 | OPC Energy | OPC-Rotem | OPC Hadera |
OPC Tzomet |
OPC-Gat | CPV Keenan |
Others | Total |
|---|---|---|---|---|---|---|---|---|
| Debt (including accrued | ||||||||
| interest) | 56 | - | 177 | 306 | 120 | 79 | 161 | 899 |
| Cash and cash equivalents (including restricted cash used |
||||||||
| for debt service) | 44 | 2 | 27 | 26 | 3 - |
93 | 195 | |
| Derivative financial instruments for hedging principal and/or |
||||||||
| interest | - | - | 10 | - | - 5 |
(1) | 14 | |
| Net debt* | 12 | (2) | 140 | 280 | 116 | 73 | 69 | 688 |
| As of December 31, 2022 | OPC Energy | OPC-Rotem | OPC-Hadera | OPC-Tzomet | CPV Keenan | Others | Total | |
| Debt (including accrued interest) | 527 | - | 190 | 237 | 88 | 1 | 1,043 | |
| Cash and cash equivalents (including restricted cash used for |
||||||||
| debt service) | 166 | 7 | 16 | 3 | 1 | 98 | 291 | |
| Net debt* | 361 | (7) | 174 | 234 | 87 | (97) | 752 |
*Net debt is defined as debt minus cash and cash equivalents and deposits and restricted cash.
This press release, including the financial tables, presents ZIM's Adjusted EBITDA, which is a non-IFRS financial measure.
ZIM defines EBITDA for each period as (loss)/profit adjusted to exclude depreciation and amortization, financing expenses, net and income tax (benefits)/expense. ZIM's Adjusted EBITDA is defined as (loss)/profit adjusted to exclude depreciation and amortization, financing expenses, net, income tax (benefits)/expense, impairments of assets, capital losses/(gains) beyond the ordinary course of business and expenses related to legal contingencies. Adjusted EBITDA is not recognized under IFRS as a measure of financial performance and should not be considered as a substitute for net profit or loss, cash flow from operations or other measures of operating performance determined in accordance with IFRS. Adjusted EBITDA is not intended to represent funds available for dividends or other discretionary uses because those funds may be required for debt service, capital expenditures, working capital and other commitments and contingencies. There are limitations that impair the use of Adjusted EBITDA as a measure of ZIM's profitability since it does not take into consideration certain costs and expenses that result from ZIM's business that could have a significant effect on net profit, such as financial expenses, taxes, and depreciation and amortization.
ZIM believes that the disclosure of Adjusted EBITDA enables the comparison of operating performance between periods on a consistent basis. This measure should not be considered in isolation, or as a substitute for operating income, any other performance measure, or cash flow data, which were prepared in accordance with IFRS as measures of profitability or liquidity. In addition, non-IFRS financial measures may not be comparable to similarly titled measures reported by other companies, due to differences in the way these measures are calculated.
Set forth below is a reconciliation of ZIM's (loss)/profit to Adjusted EBITDA for the periods presented.
| For the year ended December 31, | ||||
|---|---|---|---|---|
| 2023 | 2022 | |||
| \$ millions | ||||
| (Loss)/profit for the period | (2,688) | 4,629 | ||
| Depreciation and amortization | 1,472 | 1,396 | ||
| Financing expenses, net | 305 | 109 | ||
| Income tax (benefits)/expense | (128) | 1,398 | ||
| EBITDA | (1,039) | 7,532 | ||
| Impairment of assets | 2,063 | - | ||
| Capital losses/(gains) beyond the ordinary course of business | 20 | (1) | ||
| Expenses related to legal contingencies | 5 | 10 | ||
| Adjusted EBITDA | 1,049 | 7,541 | ||
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.